SKI Market

Indian Indices

Sensex

85,408.70 -116.14
( -0.14%)

Global Indices

Nasdaq

48,460.34 76.65
(0.16%)

Dow Jones

6,930.02 30.53
(0.44%)

Hang Seng

50,375.92 -36.95
(-0.07%)

Nikkei 225

9,896.28 30.31
(0.31%)

Forex

USD-INR

89.61 0.03
(0.04%)

EUR-INR

105.18 0.31
(0.29%)

GBP-INR

120.34 0.55
(0.45%)

JPY-INR

0.57 0.00
(0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Lal Pathlabs Ltd

Industry : Healthcare

BSE Code

ISIN Demat

Book Value()

539524

INE600L01024

139.7171745

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LALPATHLAB

44.7

23635.58

EPS(TTM)

Face Value()

Div & Yield %

31.56

0.85

Back

USFDA classifies Sun Pharma's Baska facility inspection as Official Action Indicated

Dec 18,2025

Sun Pharmaceutical Industries announced that the US FDA conducted an inspection at the Company's Baska facility from 8 September 2025 to 19 September 2025. The US FDA has subsequently determined that the inspection classification status of this facility is Official Action Indicated (OAI).

85,408.70 -116.14 ( -0.14%)

48,460.34 76.65 (0.16%)

6,930.02 30.53 (0.44%)

50,375.92 -36.95 (-0.07%)

9,896.28 30.31 (0.31%)

89.61 0.03 (0.04%)

105.18 0.31 (0.29%)

120.34 0.55 (0.45%)

0.57 0.00 (0.36%)